Market Velker et al. 1 recently reported an unusual case of adenocarcinoma arising from the minor salivary gland located on the dorsum of the posterior one third of the tongue in a 66-year-old woman. The authors interpreted the mass as adenocarcinoma not otherwise specified of minor salivary gland origin, and they provided valuable analysis of previously reported adenocarcinoma not otherwise specified in the oropharynx. However, the pathologic diagnosis of this case is questionable.
Histologically, the tumour was predominantly solid, composed of variably-sized nodules intermingled with areas of cribriform and tubular growth pattern. The neoplastic cells were cuboidal in shape, with large nuclei having small nucleoli and a clear chromatin pattern (Figure 2 in the article). Immunohistochemically, the tumour cells were positive for cytokeratin 7 and S-100, but negative for cytokeratins (34βE12, 8/18, and 20), smooth muscle actin, and smooth muscle myosin. In my opinion, the histopathologic and immunohistochemical features of this tumour were consistent with cribriform adenocarcinoma of minor salivary gland (camsg), a newly characterized salivary gland tumor 2 .
Cribriform adenocarcinoma of minor salivary gland was originally described by Michal et al. 3 in 1999 under the term "cribriform adenocarcinoma of the tongue" on a small series of 8 tumours, all affecting the tongue. It was recognized by the latest issue of the World Health Organization classification 4 as a possible variant of polymorphous low-grade adenocarcinoma, but it was not clear at that time whether it represented a genuine entity. In 2011, Skálová et al. 2 published the largest series so far, comprising 23 new cases among more than 5000 salivary gland tumours in their archives. Their study showed that camsg is a distinct tumour entity Curr Oncol, Vol. 20, pp. e610-611; doi: http://dx.doi.org/10.3747/co.20.1576
